Oliver Spandow's Insider Trades & SAST Disclosures

Oliver Spandow's most recent trade in Nephros Inc was a trade of 8,036 Common Stock done . Disclosure was reported to the exchange on Nov. 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2025 8,036 122,881 (1%) 0% 0 Common Stock
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 33,241 114,845 (1%) 0% 0 Common Stock
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 7,050 7,050 - - Stock Option (Right to Buy)
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2024 7,323 7,323 - - Stock Option (Right to Buy)
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 14,294 81,604 (0%) 0% 0 Common Stock
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 42,481 67,310 (0%) 0% 0 Common Stock
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2023 7,080 7,080 - - Stock Option (Right to Buy)
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 7,062 7,062 - - Stock Option (Right to Buy)
Nephros Inc
Oliver Spandow Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 5,429 24,829 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades